Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

ema_logo

Bioproject’s narcolepsy treatment recommended for European approval

November 20, 2015 Research and Development, Sales and Marketing

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …
News
ema_inside

Biogen’s Enbrel biosimilar gets positive CHMP opinion

November 20, 2015 Research and Development, Sales and Marketing

The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …
News
martin_shkreli_smaller_same

Turing boss Shkreli joins KaloBios as CEO; takes 70% of shares

November 20, 2015 Medical Communications, Research and Development

KaloBios Pharmaceuticals has announced the appointment of Turing CEO Martin Shkreli as its own new CEO and his election as …
Appointment
dr_allan_dunton

Alan Dunton appointed senior vice president at Purdue Pharma

November 20, 2015 Manufacturing and Production, Medical Communications, Research and Development

Purdue Pharma LP has announced the appointment of Alan Dunton, MD, to the role of senior vice president of Research …
Appointment
keytruda

Lilly and Merck extend immuno-oncology collaboration

November 20, 2015 Medical Communications, Research and Development Eli Lilly, Merck

Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …
News
bayercross3

Bayer awaits FDA decision on new contraceptive

November 20, 2015 Medical Communications, Research and Development

Bayer has submitted a new drug application (NDA) to the FDA, seeking approval for LCS-16, an investigational hormonal intrauterine device …
News
nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015 Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …
News
bayer_cross_2

NICE decision restricts Bayer’s Xofigo to select prostate cancer patients

November 19, 2015 Research and Development, Sales and Marketing Bayer, NICE, prostate cancer

NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …
News
nice

Merck criticises NICE ‘no’ to personalised bowel cancer drugs

November 19, 2015 Research and Development

NICE has issued preliminary not recommending two specific personalised treatments used in combination with chemotherapy for previously untreated metastatic colorectal …
News

NICE rejects Amgen’s Repatha in draft guidance

November 18, 2015 Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol

NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.   
News
Takeda oncology

Challenges in oncology R&D

November 18, 2015 Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …
Feature
FDA sign

FDA accepts regulatory submission for Novartis biosimilar

November 18, 2015 Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim

Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …
News
pills

Global drug spending will rise 30% by 2020, to $1.4 trillion

November 18, 2015 Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing

Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …
News
Researcher

Scientists make possible pancreatic cancer discovery

November 18, 2015 Research and Development Pancreatic cancer

Cancer researchers say they have discovered a potential new method of treatment for pancreatic cancer that could improve survival rates.  …
News
steve_turley_linkedin

UCB appoints Steve Turley as MD for Britain and Ireland

November 18, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB

Steve Turley has joined UCB as the company’s managing director for the British and Irish isles, moving from Lundbeck. He …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025